Titlebook: Redox Regulation and Therapeutic Approaches in Cancer; Mohinder Pal Bansal Book 2023 The Editor(s) (if applicable) and The Author(s), unde

惡化

書目名稱Redox Regulation and Therapeutic Approaches in Cancer影響因子(影響力)




書目名稱Redox Regulation and Therapeutic Approaches in Cancer影響因子(影響力)學(xué)科排名




書目名稱Redox Regulation and Therapeutic Approaches in Cancer網(wǎng)絡(luò)公開度




書目名稱Redox Regulation and Therapeutic Approaches in Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Redox Regulation and Therapeutic Approaches in Cancer被引頻次




書目名稱Redox Regulation and Therapeutic Approaches in Cancer被引頻次學(xué)科排名




書目名稱Redox Regulation and Therapeutic Approaches in Cancer年度引用




書目名稱Redox Regulation and Therapeutic Approaches in Cancer年度引用學(xué)科排名




書目名稱Redox Regulation and Therapeutic Approaches in Cancer讀者反饋




書目名稱Redox Regulation and Therapeutic Approaches in Cancer讀者反饋學(xué)科排名

確保

https://doi.org/10.1007/978-981-99-7342-2Redox regulation; Cancer therapy; Reactive oxygen species; Cell signaling; Metabolic reprogramming; DNA d

小隔間

Mindfulness

Perspectives in ROS/Redox Regulation Cancer Therapy,and what needs to be done. Almost each strategy discussed in previous chapters is considered for further advancement, with practicable considerations in mind. Many of the strategies, though potent in experimental stages, face challenges when transitioning to clinical applications due to the need for stringent regulation, which must be addressed.

kindred

一夫一妻制

pathophysiology of cancer.Discusses ROS and redox regulation.This book aims to provide an association of the major redox-sensitive pathways and networks involved in cancer. The initial chapter of the book discusses basic information about oxidative stress, its generation, and regulation (redox regul

ALB

植物學(xué)

ROS, Redox Regulation and Signaling in Cancer Cells, have been discussed in light of cancer development. Metabolic status in cancer cells compared to normal cells is discussed, especially in light of metabolic reprogramming in cancer cells. Further recent developments in various redox-related nanomaterials and nanoparticles for use in cancer therapy have been introduced.

Bernstein-test

exclusice

Cancer Metastasis, ROS/Redox Signaling, and PCD Resistance/Redox Metabolism,with the involvement and regulation of specially HIF-1, TGF-b, NFkB factors. Metastatic cell survival and PCD resistance have been addressed in cancer resistance development. Redox metabolic characteristics of the cancer cell link to metastasis resistance have been discussed.